Rockwell Medical reports Q4 EPS (20c), consensus (39c)

Reports Q4 revenue $19.3M, consensus $16.31M. "In 2022, Rockwell delivered on its new business strategy, achieving three consecutive quarters of improved financial performance that culminated in the highest full-year revenue to-date for the Company," said CEO Mark Strobeck. "Over the course of the year, we significantly reduced our expenses and paid down our debt. We continue to focus on enhancing efficiencies within our business as we drive towards profitability, all with the goal of benefiting patients and increasing stockholder value."